JP Patent

JP2013151522A — Ｃｏｍｔ阻害剤

Assigned to NOVIPHARMA SA · Expires 2013-08-08 · 13y expired

What this patent protects

【課題】新規ＣＯＭＴ阻害剤を提供する。【解決手段】式Ｉの新規化合物。該化合物は，中枢および末梢神経系疾患の治療において有用な薬学的特性を有する。【選択図】なし

USPTO Abstract

【課題】新規ＣＯＭＴ阻害剤を提供する。【解決手段】式Ｉの新規化合物。該化合物は，中枢および末梢神経系疾患の治療において有用な薬学的特性を有する。【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number: JP2013151522A
Jurisdiction: JP
Classification: —
Expires: 2013-08-08
Drug substance claim: No
Drug product claim: No
Assignee: NOVIPHARMA SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.